The Daily Mail Published an exclusive with Phase II stem cell clinical trial participant Robbin Gordon-Cartier. You can read the full story here. 

'I was going straight down hill, and that was that,' the New Jersey native, now 64, told DailyMail.com. The first doctor she saw diagnosed her with an advanced form of the disease that is resistant to available treatments, and affects roughly 1million Americans. 

But in 2019, a new doctor enrolled her in a clinical trial of a promising new treatment that involved using her body's own cells to fight disease. Today, five years after the injections — six over the course of one year — she's re-gained enough strength to be able to carry her own harp to concerts.

She told DailyMail.com she is far steadier on her feet, giving her the confidence to travel again, which has allowed her to resume performing at weddings and concerts.

Mrs Gordon-Cartier was one of 54 phase two patients who began receiving the new MS therapy in 2019, which was created by scientists at the Tisch MS Research Center of New York, and began its first phase in 2014. 

The treatment, which involves injecting the spine with blank-slate restorative cells, 'makes a big impact' on quality of life for MS patients, Dr Violaine Harris, the Associate Director of Research at Tisch, who ran the study, told DailyMail.com.